Pangen Signs Contract with HuonsLab for Specialized Research Services in Biopharmaceutical Process Characteristics
Huons Group's PanGen will conduct research services for Huons Lab's biopharmaceutical product approval.
PanGen announced on the 4th that it has signed a contract with Huons Lab for specialized research services on biopharmaceutical process characterization.
The total contract amount is 800 million KRW, and the process characterization research performed under this contract is a service to design a standard process suitable for commercial-scale production of biopharmaceuticals, which is essential for product approval applications. It must consider the quality characteristics of biopharmaceuticals and enable continuous production.
PanGen's Contract Development and Manufacturing Organization (CDMO) services are based on its core technology 'PanGen CHO-TECH' and biopharmaceutical productization technology. The service is provided as a one-stop solution, from establishing high-performance recombinant CHO production cell lines to contract manufacturing of non-clinical and clinical samples using GMP (Good Manufacturing Practice) production facilities.
In 2023, PanGen successfully collaborated with Huons Lab by signing a contract for the production of biopharmaceutical clinical samples and validation consignment for product approval last year. PanGen was incorporated into the Huons group in December last year.
Based on its proprietary technology for developing cell lines for biopharmaceutical production and know-how in establishing production processes, PanGen provides CDMO services for biopharmaceuticals and manufactures and sells biosimilars.
A PanGen representative stated, "Huons Group plans to strengthen its biopharmaceutical research and development (R&D) and CDMO business in the future," adding, "We will maximize synergy among Huons Group family companies to lead the healthcare market."
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Not Even Buying a Bottle of Water": BTS Fans Outraged Over Price-Gouging by Busan Accommodations
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, PanGen recorded its highest-ever sales of 14.6 billion KRW last year.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
